CONSONANCE Update Shows Ocrevus’ Effectiveness After 1 Year & Managing UTI Admissions and More

Apr 15, 2022, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how 75% of SPMS and PPMS patients in the CONSONANCE trial showed no evidence of disease progression after a year of Ocrevus treatment.
He also reads “Old Friends, Broken Chairs, UTI Admissions, and Redemption”, a column by John Connor.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/